Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11 USD | +1.38% | -19.39% | +19.67% |
Apr. 17 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 16 | Oppenheimer Upgrades Avalo Therapeutics to Outperform From Perform, Price Target is $35 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.67% | 11.22M | |
+22.57% | 44.96B | |
+0.82% | 42.65B | |
+46.00% | 41.85B | |
-4.27% | 29.04B | |
+10.72% | 26.08B | |
-20.55% | 19.03B | |
+5.31% | 12.75B | |
+27.30% | 12.06B | |
-3.98% | 11.75B |
- Stock Market
- Equities
- AVTX Stock
- News Avalo Therapeutics, Inc.
- Jefferies Downgrades Avalo Therapeutics to Hold from Buy, Adjusts Price Target to $0.75 from $5